
Amol Akhade/hiranandanihospital.org
Jun 11, 2025, 12:02
Amol Akhade: How to Improve Outcome in Advanced Ovarian Epithelial Cancer Post 1st Line Chemotherapy and Surgery?
Amol Akhade, Consultant Medical Oncologist at Suyog Cancer Clinics, shared a post on LinkedIn:
“How to improve outcome in advanced ovarian epithelial cancer post 1st line chemotherapy and surgery?
Add IO or parp inhibitors or both or none ?
Money slide to summarize all 4 new trials in this space.
Taken from ASCO25.”
Read OncoDaily’s Special Articles from ASCO25:
Highlights from ASCO 2025 Day 1
Highlights from ASCO 2025 Day 2
Highlights from ASCO 2025 Day 3
Highlights from ASCO 2025 Day 4
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 11, 2025, 10:04
Jun 11, 2025, 09:52